Correlation Between 264399ED4 and Apogee Therapeutics,
Specify exactly 2 symbols:
By analyzing existing cross correlation between DUKE PWR LLC and Apogee Therapeutics, Common, you can compare the effects of market volatilities on 264399ED4 and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 264399ED4 with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of 264399ED4 and Apogee Therapeutics,.
Diversification Opportunities for 264399ED4 and Apogee Therapeutics,
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between 264399ED4 and Apogee is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding DUKE PWR LLC and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and 264399ED4 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DUKE PWR LLC are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of 264399ED4 i.e., 264399ED4 and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between 264399ED4 and Apogee Therapeutics,
Assuming the 90 days trading horizon 264399ED4 is expected to generate 6.55 times less return on investment than Apogee Therapeutics,. But when comparing it to its historical volatility, DUKE PWR LLC is 4.49 times less risky than Apogee Therapeutics,. It trades about 0.03 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 4,169 in Apogee Therapeutics, Common on September 5, 2024 and sell it today you would earn a total of 457.00 from holding Apogee Therapeutics, Common or generate 10.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 92.0% |
| Values | Daily Returns |
DUKE PWR LLC vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| DUKE PWR LLC |
| Apogee Therapeutics, |
264399ED4 and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 264399ED4 and Apogee Therapeutics,
The main advantage of trading using opposite 264399ED4 and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 264399ED4 position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| 264399ED4 vs. Apogee Therapeutics, Common | 264399ED4 vs. Genfit | 264399ED4 vs. Vindicator Silver Lead Mining | 264399ED4 vs. Spyre Therapeutics |
| Apogee Therapeutics, vs. Axalta Coating Systems | Apogee Therapeutics, vs. Chemours Co | Apogee Therapeutics, vs. Avient Corp | Apogee Therapeutics, vs. The Mosaic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |